期刊文献+

垂体瘤转化基因小干扰RNA对人皮肤鳞状细胞癌裸鼠移植瘤中基质金属蛋白酶2和9表达的影响 被引量:3

Effect of PTTG siRNA on MMP-2 and MMP-9 expression in nude mice bearing xenografted human cutaneous squamous cell carcinoma
原文传递
导出
摘要 目的探讨垂体瘤转化基因(mG)小干扰RNA(siRNA)对人皮肤鳞状细胞癌(鳞癌)裸鼠移植瘤生长及浸润和转移相关因子基质金属蛋白酶(MMP)2、9表达的影响。方法应用人皮肤鳞癌细胞株SCL-1细胞建立裸鼠皮下移植瘤模型,观察经FITGsiRNA治疗后移植瘤的生长情况,并利用RT-PCR和Western印迹检测glTGsiRNA治疗后PTrG、MMP-2及MMP-9mRNA和蛋白的表达。结果成功建立人皮肤鳞癌裸鼠皮下移植瘤模型,PTFGsiRNA治疗能明显抑制瘤体的生长(P〈0.05),并下调PTFGmRNA和蛋白的表达。此外,tWFGsiRNA治疗组中其MMP-2和MMP-9的表达均明显下调。结论PTFGsiRNA能抑制人皮肤鳞癌裸鼠移植瘤的生长,并下调MMP-2和MMP-9表达。 Objective To investigate the effect of pituitary tumor-transforming gene (PTTG) siRNA on the growth, invasion of, and expression of metastasis-related cytokines including matrix metalloproteinase-2 (MMP-2) and MMP-9 in xenografted human cutaneous squamous cell carcinoma in nude mice. Methods SCL-1 cells were subcutaneously inoculated into Balb/c nude mice to establish a xenograft model of human cutaneous squamous cell carcinoma. Then, 15 mice bearing xenografted carcinoma were equally divided into 3 groups to be inoculated with phosphate buffer saline (PBS), control siRNA, and P'ITG siRNA of 50 nmol/L, respectively, every other day for 2 weeks. The size of xenograted carcinoma in these mice was measured every other day. At the end of 2-week treatment, the mice were killed followed by the evaluation of tumor weight, as well as the quantification of mRNA and protein expression of PTTG, MMP-2 and MMP-9 by reverse transcrip- tion (RT)-PCR and Western-blot, respectively. Results The xenograft model of human cutaneous squamous cell carcinoma was successfully established. The treatment with PTTG siRNA obviously inhibited the growth of the xenografted tumors and the expression of trITG mRNA and protein compared with PBS and control siRNA (all P 〈 0.05). In addition, the expression of MMP-2 and MMP-9 in xenografted tumors in PTTG siRNA- treated mice were significantly lower than those in PBS and control siRNA-treated mice, suggesting that PTYG siRNA evoked the decrease in invasive and metastatic ability of xenografted tumors. Conclusions PTTG siRNA can inhibit the growth of human cutaneous squamous cell carcinoma xenografts in nude mice, and downregulate the expression of invasion- and metastasis-related cytokines, including MMP-2 and MMP-9.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2011年第7期494-496,共3页 Chinese Journal of Dermatology
基金 河南省高校科技创新人才支持计划(2009HASTIT030) 河南省卫生科技创新型人才工程专项经费(4159)
关键词 癌基因 鳞状细胞 RNA 小分子干扰 基质金属蛋白酶2 基质金属蛋白酶9 异种移植模型抗肿瘤试验 Oncogenes Carcinoma, squamous cell RNA, small interfering Matrix metalloproteinase2 Matrix metalloproteinase 9 Xenograft model antitumor assays
  • 相关文献

参考文献3

二级参考文献14

  • 1陈刚,李静,李辅军,李箫,周剑锋,卢运萍,马丁.Inhibitory Effects of Anti-sense PTTG on Malignant Phenotype of Human Ovarian Carcinoma Cell Line SK-OV-3[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2004,24(4):369-372. 被引量:10
  • 2侯桂琴,刘明月,薛乐勋,鲁照明,范天黎,高媛,许培荣,刘兰琦.雷帕霉素对食管鳞癌细胞系EC9706的mTOR/p70S6K信号通路的影响[J].肿瘤,2007,27(3):172-175. 被引量:7
  • 3PENE F, CLAESSENE YE, MULLER O, et al. Role of the phosphatidylinositol 3-kinase/AKT and mTOR/p70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma[ J]. Oncogene, 2002, 21(43):6587-6597.
  • 4PANWALKER A,VERSTOVSEK S,GILES FJ. Mammalian target of rapamycin as therapy for hematologic malignancies[J]. Cancer, 2004,100(4) :657-666.
  • 5BJORNSTI MA, HOUGHTON PJ. The TOR pathway: a target for cancer therapy[ J]. Nat Rev Cancer, 2004, 4(5) :335-348.
  • 6ALBERT JM,KIM KW,CAO C, et al. Targeting the Akt/mammalian target of rapamycin pathway for radiosensitization of breast cancer[J]. Mol Cancer Ther , 2006,5(5) :1183-1189.
  • 7GUBA M, BREITENBUCH PV, STEINBAUER M, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis involvement of vascular endothelial growth factor[J]. Nat Med, 2002, 8(2) :128-13.5.
  • 8ASANO T, YAO Y, ZHU J, et al. The rapamycin anolog CCI-779 is a potent inhibitor of pancreatic cancer cell proliferation [ J ]. Biochem Biophys Res Commun, 2005, 331 ( 1 ) :295-302.
  • 9HOU G Q, XUE L X, LU Z M, et al. mTOR/p70S6K signaling pathway constitutively activated in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR [J]. Cancer Lett, 2007, 253 (2) :236-248.
  • 10ROWINSKY E K. Targeting the molecular target of rapamycin (mTOR) [J]. Curr Opin Oncol, 2004, 16(6) : 564-575.

共引文献20

同被引文献25

  • 1Pei L, Melmed S, Isolation and characterization of a pituitary tumor- transforming gene (PTFG). Mol Endocrinol, 1997, 11 (4): 433- 441.
  • 2Berdiaki A, Nikitovic D, Tsatsakis A, et al. bFGF induces changes in hyaluronan synthase and hyaluronidase isoform expression and modulates the migration capacity of fibrosarcoma cells. Biochim Biophys Acta, 2009, 1790(10): 1258-1265.
  • 3Chamaon K, Kanakis D, Mawrin C, et al. Transcripts of PTI'G and growth factors bFGF and IGF-1 are correlated in pituitary adenomas. Exp Clin Endocrinol Diabetes, 2010, 118(2): 121-126.
  • 4Guigon CJ, Cheng SY. Novel non-genomic signaling of thyroidhormone ~ceptors in thyroid carcinogenesis. Mol Cell Endocrinol, 2009, 308( 1-2): 63-69.
  • 5Yan S, Zhou C, Lou X, et al. PTTG overexpression promotes lymph node metastasis in human esophageal squamoos cell carcinoma. Cancer Res, 2009, 69(8): 3283-3290.
  • 6] Pan H, Gao F, Papageorgis P, et al. Aberrant activation of gamma- catenin promotes genomic instability and oncogenic effects during tumor progression. Cancer Biol Ther, 2007, 6( 10): 1638-1643.
  • 7Marzioni D, l,orenzi T, Mazzucchelli R, et al. Expression of basic fibroblast growth factor, its receptors and syndecans in bladder cancer, lnt J Immunopathol Pharmacol, 2009, 22(3): 627-638.
  • 8Xu Y, Zhang SZ, Huang CH, et al. Keratin 17 identified by pro-teomic analysis may be involved in tumor angiogenesis. BMB Rep, 2009, 42(6): 344-349.
  • 9Hamid T, Malik MT, Kakar SS. Ectopic expression of PTTGI/ securin promotes tumorigenesis in human embryonic kidney cells. Mol Cancer, 2005, 4( 1 ): 3.
  • 10Stratford AL, Boelaert K, Tannahill LA, et al. Pituitary tumor transforming gene binding factor: a novel transforming gene in thyroid tumorigenesis. J Clin Endocrinol Metab, 2005, 90 (7): 4341-4349.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部